Cargando…
Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity
Phytoestrogens (PEs) are plant-based compounds that can interact with estrogen receptors and are mainly used to treat menopausal complaints. However, the safety of products with assumed phytoestrogenic activity is not fully understood. This study aimed to identify plant species with assumed phytoest...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459077/ https://www.ncbi.nlm.nih.gov/pubmed/37631050 http://dx.doi.org/10.3390/ph16081137 |
_version_ | 1785097321993732096 |
---|---|
author | Tjeerdsma, A. Marije van Hunsel, Florence P. A. M. van de Koppel, Sonja Ekhart, Corine Vitalone, Annabella Woerdenbag, Herman J. |
author_facet | Tjeerdsma, A. Marije van Hunsel, Florence P. A. M. van de Koppel, Sonja Ekhart, Corine Vitalone, Annabella Woerdenbag, Herman J. |
author_sort | Tjeerdsma, A. Marije |
collection | PubMed |
description | Phytoestrogens (PEs) are plant-based compounds that can interact with estrogen receptors and are mainly used to treat menopausal complaints. However, the safety of products with assumed phytoestrogenic activity is not fully understood. This study aimed to identify plant species with assumed phytoestrogenic activity, review existing literature on their use and safety, and critically evaluate adverse reaction (AR) reports of single-herb, multi-herb, and mixed-multiple products, as submitted to the Netherlands Pharmacovigilance Centre Lareb and to VigiBase of the World Health Organization (WHO). In the Lareb database, the most commonly reported plant species to cause ARs (total of 67 reports) were Actaea racemosa L. (black cohosh) (47.8%), Humulus lupulus L. (hops) (32.8%), and Glycine max (L.) Merr. (soybean) (22.4%). In the VigiBase database (total of 21,944 reports), the top three consisted of Glycine max (L.) Merr. (71.4%), Actaea racemosa L. (11.6%), and Vitex agnus-castus L. (chaste tree) (6.4%). In the scoping review (total of 73 articles), Actaea racemosa L. (30.1%), Glycine max (L.) Merr. (28.8%), and Trifolium pratense L. (13.7%) were the most frequently mentioned plant species. ARs were most frequently reported in the system organ classes “gastrointestinal disorders”, “skin and subcutaneous tissue disorders”, “reproductive system and breast disorders”, and “general disorders and administration site conditions”. Furthermore, from the scoping review, it appeared that the use of products with assumed phytoestrogenic activity was associated with postmenopausal bleeding. It was concluded that, while the potential benefits of products with assumed phytoestrogenic activity have been extensively pursued, the potential occurrence of ARs after using these products is less well understood. This study highlights the need for further investigation and careful monitoring of these products to better understand their effects and ensure the safety and well-being of individuals using them. |
format | Online Article Text |
id | pubmed-10459077 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-104590772023-08-27 Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity Tjeerdsma, A. Marije van Hunsel, Florence P. A. M. van de Koppel, Sonja Ekhart, Corine Vitalone, Annabella Woerdenbag, Herman J. Pharmaceuticals (Basel) Article Phytoestrogens (PEs) are plant-based compounds that can interact with estrogen receptors and are mainly used to treat menopausal complaints. However, the safety of products with assumed phytoestrogenic activity is not fully understood. This study aimed to identify plant species with assumed phytoestrogenic activity, review existing literature on their use and safety, and critically evaluate adverse reaction (AR) reports of single-herb, multi-herb, and mixed-multiple products, as submitted to the Netherlands Pharmacovigilance Centre Lareb and to VigiBase of the World Health Organization (WHO). In the Lareb database, the most commonly reported plant species to cause ARs (total of 67 reports) were Actaea racemosa L. (black cohosh) (47.8%), Humulus lupulus L. (hops) (32.8%), and Glycine max (L.) Merr. (soybean) (22.4%). In the VigiBase database (total of 21,944 reports), the top three consisted of Glycine max (L.) Merr. (71.4%), Actaea racemosa L. (11.6%), and Vitex agnus-castus L. (chaste tree) (6.4%). In the scoping review (total of 73 articles), Actaea racemosa L. (30.1%), Glycine max (L.) Merr. (28.8%), and Trifolium pratense L. (13.7%) were the most frequently mentioned plant species. ARs were most frequently reported in the system organ classes “gastrointestinal disorders”, “skin and subcutaneous tissue disorders”, “reproductive system and breast disorders”, and “general disorders and administration site conditions”. Furthermore, from the scoping review, it appeared that the use of products with assumed phytoestrogenic activity was associated with postmenopausal bleeding. It was concluded that, while the potential benefits of products with assumed phytoestrogenic activity have been extensively pursued, the potential occurrence of ARs after using these products is less well understood. This study highlights the need for further investigation and careful monitoring of these products to better understand their effects and ensure the safety and well-being of individuals using them. MDPI 2023-08-10 /pmc/articles/PMC10459077/ /pubmed/37631050 http://dx.doi.org/10.3390/ph16081137 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tjeerdsma, A. Marije van Hunsel, Florence P. A. M. van de Koppel, Sonja Ekhart, Corine Vitalone, Annabella Woerdenbag, Herman J. Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity |
title | Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity |
title_full | Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity |
title_fullStr | Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity |
title_full_unstemmed | Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity |
title_short | Analysis of Safety Concerns on Herbal Products with Assumed Phytoestrogenic Activity |
title_sort | analysis of safety concerns on herbal products with assumed phytoestrogenic activity |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459077/ https://www.ncbi.nlm.nih.gov/pubmed/37631050 http://dx.doi.org/10.3390/ph16081137 |
work_keys_str_mv | AT tjeerdsmaamarije analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity AT vanhunselflorencepam analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity AT vandekoppelsonja analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity AT ekhartcorine analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity AT vitaloneannabella analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity AT woerdenbaghermanj analysisofsafetyconcernsonherbalproductswithassumedphytoestrogenicactivity |